Want to see GB:PHSC full AI Analyst Report?
Top Page
PHSC plc
(LSE:PHSC)
Select Model
Select Model
Rating:48Neutral
Price Target:
7.50 p
▼(-3.23% Downside)
Action:Reiterated
Date:08/03/26
The score is primarily held back by weakening operating performance and, most importantly, the swing to negative operating and free cash flow in 2026. A low-debt balance sheet is a meaningful stabilizer, but technicals show weak longer-term trend and valuation support is limited due to losses (negative P/E) and no stated dividend yield.
Positive Factors
Conservative Balance Sheet
Very low leverage provides a durable financial buffer and optionality: it lowers refinancing risk, preserves access to credit, and gives management flexibility to fund operations, support clients, or pursue small M&A even while earnings are weak, stabilizing the business over months.
Negative Factors
Negative Cash Flow
The swing to negative operating and free cash flow undermines self-funding and increases reliance on external financing or asset drawdown. Over a 2–6 month horizon this raises liquidity risk, constrains investment in client services, and pressures working-capital management and supplier relationships.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Very low leverage provides a durable financial buffer and optionality: it lowers refinancing risk, preserves access to credit, and gives management flexibility to fund operations, support clients, or pursue small M&A even while earnings are weak, stabilizing the business over months.
Read all positive factors
PHSC plc (PHSC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£796.77K
Dividend YieldN/A
Average Volume (3M)11.43K
Price to Earnings (P/E)―
Beta (1Y)-0.35
Revenue Growth2.41%
EPS Growth-141.46%
CountryUK
Employees39
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,280,853
10 Day Avg. Volume8,259
30 Day Avg. Volume11,428
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.30
Price to Sales (P/S)0.25
P/FCF Ratio-3.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PHSC plc Business Overview & Revenue Model
Company Description
PHSC plc provides a comprehensive range of health, safety, hygiene, environmental, and quality systems consultancy and training services to organizations across the United Kingdom. The company also offers security solutions including tagging, labe...
How the Company Makes Money
PHSC plc makes money primarily by charging organisations for outsourced services and specialist support related to workplace health, safety, and compliance. Key revenue streams typically include (1) service fees for delivering training courses (in...
PHSC plc Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
72
Positive
Cash Flow
38
Negative
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.30M | 3.22M | 3.78M | 3.44M | 3.57M |
| Gross Profit | 1.59M | 1.67M | 2.02M | 1.83M | 1.63M |
| EBITDA | -126.36K | 43.85K | 509.52K | 366.29K | 274.04K |
| Net Income | -305.35K | -126.20K | 248.76K | 243.26K | -631.00K |
Balance Sheet | |||||
| Total Assets | 3.49M | 3.76M | 4.13M | 4.34M | 4.30M |
| Cash, Cash Equivalents and Short-Term Investments | 385.34K | 434.80K | 488.38K | 749.63K | 649.36K |
| Total Debt | 77.78K | 102.48K | 79.33K | 50.55K | 54.82K |
| Total Liabilities | 772.62K | 741.12K | 856.71K | 701.12K | 788.85K |
| Stockholders Equity | 2.72M | 3.02M | 3.28M | 3.64M | 3.51M |
Cash Flow | |||||
| Free Cash Flow | -213.41K | 104.25K | 375.25K | 221.65K | 202.20K |
| Operating Cash Flow | -154.27K | 119.65K | 414.86K | 263.04K | 224.32K |
| Investing Cash Flow | 129.52K | 1.77K | -22.30K | -40.04K | -21.59K |
| Financing Cash Flow | -24.70K | -175.00K | -653.81K | -122.73K | -790.85K |
PHSC plc Technical Analysis
Neutral
7.75
Price Trends
7.75
Positive
7.86
Negative
8.58
Negative
Market Momentum
>-0.01
Negative
46.48
Neutral
49.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:PHSC, the sentiment is Neutral. The current price of 7.75 is equal to the 20-day moving average (MA) of 7.75, above the 50-day MA of 7.75, and below the 200-day MA of 8.58, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.48 is Neutral, neither overbought nor oversold. The STOCH value of 49.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:PHSC.
PHSC plc Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £4.10M | 6.12 | 31.30% | ― | 38.67% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | £3.56M | 17.33 | 14.23% | ― | 20.42% | ― | |
48 Neutral | £796.77K | -2.61 | -7.45% | ― | 2.41% | -141.46% | |
43 Neutral | £6.07M | -14.93 | -6.73% | ― | 24.39% | 65.82% | |
39 Underperform | £1.19M | -2.04 | 219.72% | ― | 50.44% | 21.70% | |
37 Underperform | £8.51M | -11.54 | -29.93% | ― | ― | ― |
* Industrials Sector Average
GB:PHSC
PHSC plc
7.75
-3.75
-32.61%
GB:CEPS
CEPS plc
40.50
10.50
35.00%
GB:IGE
Image Scan Holdings
2.60
1.15
79.31%
GB:NBB
Norman Broadbent
204.00
-27.50
-11.88%
GB:PEG
Petards
10.00
1.50
17.65%
GB:SNT
Sabien Technology
3.75
-3.00
-44.44%
PHSC plc Corporate Events
Business Operations and StrategyFinancial Disclosures
PHSC edges up revenue but posts loss as margins tighten
Negative
May 26, 2026
PHSC plc, a UK provider of health, safety and quality consultancy and training services alongside tagging, labelling and CCTV security solutions, reported unaudited revenues of about £3.30m for the year to 31 March 2026, up slightly from ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.